Paolo Tarantino, PhD in clinical research at the University of Milan, shared a post on X:
“Incredibly proud to be part of this amazing, fun, bright, motivated, international group of ESMO Ambassadors.
Shoutout to Antonio Passaro for the terrific leadership!”
Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan. His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.